ArticleJournal of the Chinese Medical Association : JCMA2026
Bushen Huoxue recipe regulates endometrial epithelial ion channels to promote embryo implantation in controlled ovarian hyperstimulation mice.
Article in Journal of the Chinese Medical Association : JCMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundControlled ovarian hyperstimulation (COH) is commonly used to obtain large numbers of high-quality oocytes. However, elevated estrogen levels due to COH can disrupt uterine fluid metabolism and impair embryonic implantation. We investigated the effects and mechanisms of Bushen Huoxue recipe (BSHX) on COH-induced impairment of endometrial receptivity.
methodsFemale mice were randomly divided into the following five groups: control, model, BSHX-L, BSHX-M, and BSHX-H. In addition to the control group, the COH model was established by injecting mice in the other groups with 0.4 IU/g pregnant mare serum gonadotropin and 1 IU/g human chorionic gonadotropin. After successful mating, mice in the BSHX-L, BSHX-M, and BSHX-H groups were treated with 5.5, 11.0, and 22.0 g/kg, respectively. Mice in the control and model groups were administered distilled water (10 mL/kg) daily via gavage. Embryo numbers were examined on embryo day 10 (D10). Serum estradiol and progesterone levels were measured using an enzyme-linked immunosorbent assay on D4. Endometrial morphology was analyzed using hematoxylin-eosin staining. The protein and gene expression of leukemia inhibitory factor (LIF), cystic fibrosis transmembrane regulator (CFTR), and epithelial sodium channel (ENaC) subunits were assessed using immunohistochemistry, western blotting, and quantitative real-time polymerase chain reaction.
resultsBSHX treatment reduced superphysiological serum estradiol and progesterone levels, improved endometrial morphology during the implantation window, upregulated LIF, α-, β-, and γ-ENaC expression, and downregulated CFTR expression, thereby enhancing embryo implantation.
conclusionBSHX may improve assisted reproductive technology pregnancy rates by regulating sex hormones and uterine fluid balance to prevent COH-induced endometrial damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.